ProQR Therapeutics Q3 EPS $(0.10) Beats $(0.11) Estimate, Sales $5.933M Beat $5.350M Estimate
Benzinga Newsdesk 3 hours ago
NewsEarningsEarnings Beats
ProQR Therapeutics (NASDAQ:PRQR) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 9.09 percent increase over losses of $(0.12) per share from
ProQR Therapeutics (NASDAQ:PRQR) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 9.09 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $5.933 million which beat the analyst consensus estimate of $5.350 million by 10.90 percent. This is a 78.87 percent increase over sales of $3.317 million the same period last year.